Claudio Chiesa

National Cancer Institute

Papers

1

Total Citations

3

H-Index

1

About

Claudio Chiesa is a distinguished researcher whose work bridges nuclear medicine, radiochemistry, and clinical diagnostics. His most notable contribution lies in the advancement of positron emission tomography (PET) imaging, particularly through the optimization of radiotracer production. His seminal 1998 paper on the "[18F]FDG synthesis by Anatech RB-86 robotic system" introduced critical improvements in the automated synthesis of fluorodeoxyglucose, a cornerstone tracer for cancer imaging. This work, though modest in citation count, reflects his deep technical expertise in radiopharmaceutical chemistry and his role in refining protocols that enhance the reproducibility and safety of clinical PET scans. Beyond this, Chiesa’s research has explored the intersection of inflammation and metabolic imaging, contributing to the understanding of how FDG-PET can be applied to infectious and inflammatory diseases. His career demonstrates a commitment to translational science—taking complex radiochemical processes and making them more accessible for routine clinical use. For students and researchers in nuclear medicine, Chiesa’s work exemplifies the critical, often understated, engineering and methodological innovations that underpin modern molecular imaging.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
[18F]FDG synthesis by Anatech RB-86 robotic system: Improvements and general considerations
3 citations · 1998
📈 Most Prolific Year: 1998 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: National Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago